Plain-English translation of NCT07622628 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a daily oral supplement called a microbiome-targeted nutritional formulation that was designed using artificial intelligence to help improve blood sugar control in adults with type 2 diabetes. The medication works by targeting your gut bacteria, which may help your body regulate blood sugar better. You would take this treatment once daily for 24 weeks while continuing your regular diabetes medicines and receiving nutrition counseling.
Many people with type 2 diabetes still struggle with high blood sugar even when taking standard medications. This trial is exploring whether supporting a healthier gut microbiome through nutrition could be a safe additional tool to help improve blood sugar control without replacing existing diabetes care.
You likely qualify if…
You likely don't qualify if…
Over 24 weeks, you would take either the active supplement or a matching placebo once daily (as a sachet and capsule). Both groups receive identical nutrition and lifestyle counseling and continue taking your regular diabetes medications. You would have study visits for blood tests and stool samples, and the researchers will monitor your blood sugar control throughout the trial.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Turkey (Türkiye)